Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Phcog.Net JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS Volume 7 · Issue 4 2016 · pp. 155–198
    Search this issue

    Cover: Journal of Pharmacology and Pharmacotherapeutics

    Journal of Pharmacology and Pharmacotherapeutics

    Volume 7, Issue 4

    2016 · pp. 155–198 · 10 articles

    Volume
    7
    Issue
    4
    Published
    2016
    Pages
    155–198
    Articles
    10
    Sections
    6
    ISSN
    ISSN: Print - 0976-500X, Online - 0976-5018
    Journal
    J Pharmacol. Pharmacother.

    In this issue

    Review Article

    1. Review

      Lesinurad: A significant advancement or just another addition to existing therapies of gout?

      Ajay Gupta, Pramod Kumar Sharma, Arup Kumar Misra, Surjit Singh

      pp. 155–158 · DOI: 10.4103/0976-500X.195897 · Published 2016

      Gout is a metabolic disorder that usually presents as recurrent episodes of acute arthritis due to deposition of crystals in joints and cartilages. Despite the availability of several drugs for gout, its management is st

    Research Paper

    1. Article

      Hypertension influences the exponential progression of inflammation and oxidative stress in streptozotocin‑induced diabetic kidney

      Rupadevi Muthaian, Rajaa Muthu Pakirisamy, Subramani Parasuraman, Ramasamy Raveendran

      pp. 159–164 · DOI: 10.4103/0976-500X.195898 · Published 2016

      Objective: To investigate the association of hypertension coexisting with diabetes mellitus with oxidative stress and inflammation in the kidneys of streptozotocin (STZ)‑induced diabetic rats. Materials and Methods: Male

    2. Article

      QTc interval in young Gujarati hypertensives: Effect of disease, antihypertensive monotherapy, and coexisting risk factors

      Jayesh Dalpatbhai Solanki, Bhakti P. Gadhavi, Amit H. Makwana, Hemant B. Mehta, Chinmay J. Shah

      pp. 165–170 · DOI: 10.4103/0976-500X.195900 · Published 2016

      Objectives: To study the effect of disease duration, treatment and risk factors on QTc interval among young hypertensives. Materials and Methods: A case–control study was conducted on 142 hypertensives (60 males, 82 fema

    3. Article

      Comparison of efficacy, safety, and cost‑effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double‑blind, parallel group study

      Ganesh Dakhale, Yogesh Tathod, Seema Patel, Sonali Pimpalkhute, Latesh Raghute, Ajita Khamkar

      pp. 171–176 · DOI: 10.4103/0976-500X.195901 · Published 2016

      Objective: To compare the efficacy, safety, and cost‑effectiveness of rupatadine and olopatadine in patients of allergic rhinitis (AR). Materials and Methods: A 2‑week, single‑centered, randomized, double‑blind, parallel

    4. Article

      Inhibition by tadalafil of contractility of isolated nonpregnant human myometrium

      Sumalya Sen, Anitha Thomas, Saibal Das, Jayanta Kumar Dey, Abraham Peedicayil, Vinotha Thomas

      pp. 177–181 · DOI: 10.4103/0976-500X.195902 · Published 2016

      Objective: To investigate the inhibitory effect of tadalafil on the contractility of isolated nonpregnant human myometrium. Materials and Methods: The ability of tadalafil (25, 40, and 63 µM) to inhibit 55 mM KCl‑induced

    Case Report

    1. Article

      Clozapine‑induced cataract in a young female

      Md. Shahid Alam, K. V. Praveen Kumar

      pp. 184–186 · DOI: 10.4103/0976-500X.195904 · Published 2016

      A variety of systemic drugs including corticosteroids, amiodarone and antipsychotics have been known to cause cataract formation. Typical antipsychotics such as chlorpromazine have been reported to cause cataract formati

    2. Article

      Presumed isotretinoin-induced extraocular myopathy

      Md. Shahid Alam, Swati Agarwal

      pp. 187–9 · DOI: 10.4103/0976-500X.195905 · Published 2016

      Isotretinoin a synthetic analogue of vitamin A is primarily used for cystic acne not responding to conventional treatment. Several ocular side effects including blurring of vision, decreased dark adaptation, corneal opac

    Molecules of Millennium

    1. Article

      Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia

      Faizan Mazhar, Nafis Haider

      pp. 190–3 · DOI: 10.4103/0976-500X.195906 · Published 2016

      The treatment of hypercholesterolemia entered in a new phase of development with the introduction of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in the market. The Food and Drug Administration and Eu

    1. Article

      Lifitegrast: A novel drug for treatment of dry eye disease

      Afroz Abidi, Pooja Shukla, Ali Ahmad

      pp. 194–198 · DOI: 10.4103/0976-500X.195920 · Published 2016

      Dry eye disease (DED) is an inflammatory disorder of ocular surfaces leading to severe disability, especially in the elderly age group. The mainstay of therapy includes artificial tears, punctual plugs, topical anti- inf

    Research Letter

    1. Article

      Analgesics self-medication among undergraduate students of a Rural Medical College

      Amit Kumar, Vandana Vandana, Ahmad Nadeem Aslami

      pp. 182–3 · DOI: 10.4103/0976-500X.195903 · Published 26 October 2016

      The data were analyzed by descriptive and inferential statistics. Odds ratio and Chi-square test were applied. The sum of percentages is not always 100% as some questions contained multiple responses. A total of 308 comp